Erick DeVinney
Equibles does not estimate personal net worth.
Get an email with a short summary when Axogen, Inc. publishes a filing, an earnings call transcript or a press release.
Get AXGN alertsAbout Erick DeVinney
The proxy statement of Axogen, Inc. reports total compensation of $2,261,741 for Erick DeVinney in fiscal 2025, including a base salary of $414,607. Disclosed compensation is on record for 5 fiscal years. Axogen, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Axogen, Inc. includes Michael Dale (CEO and Board Member), Paul G. Thomas (Chairman and Board Member), Paul Thomas (Chairman) and 7 others.
Affiliation history
-
Axogen, Inc. (AXGN)
Proxy statement
CurrentStart not stated–present
Last confirmed April 29, 2026
Company network
Leadership on record at Axogen, Inc.
- Michael Dale CEO, Board Member
- Paul G. Thomas Chairman, Board Member
- Paul Thomas Chairman
- Lindsey Hartley CFO
- Brad Ottinger General Counsel
- Bradley Ottinger General Counsel
- Alan Levine Board Member
- Alan M. Levine Board Member
- Amy Wendell Board Member
- John H. Johnson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Axogen, Inc. (AXGN) | Chief Innovation Officer | $414,607 | $2,261,741 |
| 2024 | Axogen, Inc. (AXGN) | Chief Innovation Officer | $400,318 | $2,266,567 |
| 2023 | Axogen, Inc. (AXGN) | Chief Innovation Officer | $348,000 | $1,505,697 |
| 2022 | Axogen, Inc. (AXGN) | Chief Innovation Officer | — | — |
| 2021 | Axogen, Inc. (AXGN) | Vice President , Peripheral Nerve Science | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.